According to the Consensus Statement for Standard of Care in Spinal Muscular Atrophy, the first diagnostic test for patients with suspected SMA should be genetic analysis for deletions in the SMN gene. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.